Targeting cytokine and chemokine signaling pathways for cancer therapy
M Yi, T Li, M Niu, H Zhang, Y Wu, K Wu… - Signal transduction and …, 2024 - nature.com
Cytokines are critical in regulating immune responses and cellular behavior, playing dual
roles in both normal physiology and the pathology of diseases such as cancer. These …
roles in both normal physiology and the pathology of diseases such as cancer. These …
FGFR-targeted therapeutics: Clinical activity, mechanisms of resistance and new directions
Fibroblast growth factor (FGF) signalling via FGF receptors (FGFR1–4) orchestrates fetal
development and contributes to tissue and whole-body homeostasis, but can also promote …
development and contributes to tissue and whole-body homeostasis, but can also promote …
Landscape of clinical resistance mechanisms to FGFR inhibitors in FGFR2-altered cholangiocarcinoma
Q Wu, H Ellis, G Siravegna, AG Michel, BL Norden… - Clinical Cancer …, 2024 - AACR
Purpose: FGFR inhibitors are effective in FGFR2-altered cholangiocarcinoma, leading to
approval of reversible FGFR inhibitors, pemigatinib and infigratinib, and an irreversible …
approval of reversible FGFR inhibitors, pemigatinib and infigratinib, and an irreversible …
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies
F Facchinetti, Y Loriot, F Brayé, D Vasseur… - Clinical Cancer …, 2024 - aacrjournals.org
Purpose: Understanding resistance to selective FGFR inhibitors is crucial to improve the
clinical outcomes of patients with FGFR2-driven malignancies. Experimental Design: We …
clinical outcomes of patients with FGFR2-driven malignancies. Experimental Design: We …
Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment
Z Wang, F Miao, L Gu, R Zhang, Y Ma, Y Li, J Zheng… - ACS …, 2024 - ACS Publications
Fibrosarcoma, a malignant mesenchymal tumor, is characterized by aggressive
invasiveness and a high recurrence rate, leading to poor prognosis. Anthracycline drugs …
invasiveness and a high recurrence rate, leading to poor prognosis. Anthracycline drugs …
New clinical trial design in precision medicine: discovery, development and direction
XP Duan, BD Qin, XD Jiao, K Liu, Z Wang… - Signal Transduction and …, 2024 - nature.com
In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …
certain disease are complex and different from each other. Due to the underestimation of the …
FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially …
MF Sabbagh, T Janovitz, D Dias-Santagata… - Thyroid, 2024 - liebertpub.com
Background: Diagnostic classification of thyroid malignancy is primarily accomplished
through examination of histomorphological features and may be substantiated and clarified …
through examination of histomorphological features and may be substantiated and clarified …
Molecular profiling and targeted therapies in gliomas
Y Felistia, PY Wen - Current Neurology and Neuroscience Reports, 2023 - Springer
Abstract Purpose of Review Molecular profiling enables the evaluation of genetic alterations
for the diagnosis and classification of gliomas and the selection of appropriate therapies …
for the diagnosis and classification of gliomas and the selection of appropriate therapies …
[HTML][HTML] Empowering effective biomarker-driven precision oncology: A call to action
M Lawler, P Keeling, O Kholmanskikh… - European Journal of …, 2024 - Elsevier
Precision oncology has a significant role to play in delivering optimal patient care.
Biomarkers are critical enablers for precision oncology across the continuum of cancer …
Biomarkers are critical enablers for precision oncology across the continuum of cancer …
Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma
A Lamarca, L Ostios, MG McNamara, C Garzon… - Cancer Treatment …, 2023 - Elsevier
Precision medicine is a major achievement that has impacted on management of patients
diagnosed with advanced cholangiocarcinoma (CCA) over the last decade. Molecular …
diagnosed with advanced cholangiocarcinoma (CCA) over the last decade. Molecular …